Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Marco Aurelio P. Safadi, Federico Martinón-Torres, Lidia Serra, Cynthia Burman & Jessica Presa. (2021) Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Review of Vaccines 20:4, pages 401-414.
Read now
Read now
Rouba Shaker, Danielle Fayad & Ghassan Dbaibo. (2018) Challenges and opportunities for meningococcal vaccination in the developing world. Human Vaccines & Immunotherapeutics 14:5, pages 1084-1097.
Read now
Read now
Shina Pashova, Christoph Schneider, Stephan von Gunten & Anastas Pashov. (2017) Antibody repertoire profiling with mimotope arrays. Human Vaccines & Immunotherapeutics 13:2, pages 314-322.
Read now
Read now
Roberto Gasparini, Paolo Landa, Daniela Amicizia, Giancarlo Icardi, Walter Ricciardi, Chiara de Waure, Elena Tanfani, Paolo Bonanni, Carlo Lucioni, Angela Testi & Donatella Panatto. (2016) Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis. Human Vaccines & Immunotherapeutics 12:8, pages 2148-2161.
Read now
Read now
Michael J. McCluskie, Dana M. Evans, Ningli Zhang, Michelle Benoit, Susan P. McElhiney, Manu Unnithan, Suzanne C. DeMarco, Bryan Clay, Christoph Huber, Aparna Deora, Jennifer M. Thorn, David R. Stead, James R. Merson & Heather L. Davis. (2016) The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines. Immunopharmacology and Immunotoxicology 38:3, pages 184-196.
Read now
Read now
Mairi Vella & David Pace. (2015) Glycoconjugate vaccines: an update. Expert Opinion on Biological Therapy 15:4, pages 529-546.
Read now
Read now
Articles from other publishers (41)
Davide Oldrini, Roberta Di Benedetto, Martina Carducci, Daniele De Simone, Luisa Massai, Renzo Alfini, Barbara Galli, Brunella Brunelli, Amanda Przedpelski, Joseph T. Barbieri, Omar Rossi, Carlo Giannelli, Rino Rappuoli, Francesco Berti & Francesca Micoli. (2023) Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines. Vaccines 11:12, pages 1770.
Crossref
Crossref
Sabina Koj, Czeslaw Lugowski & Tomasz Niedziela. (2023) In-cell depolymerization of polysaccharide antigens. Exploring the processing pathways of glycans and why some glycoconjugate vaccines are less effective than expected: A review. Carbohydrate Polymers 315, pages 120969.
Crossref
Crossref
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica Romero, Oscar Samón-Tabio, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Sonsire Fernández-Castillo, Yanet Climent-Ruiz, Yury Valdes-Balbín, Dagmar García-Rivera, Patrick Van der Stuyft & Vicente Verez-Bencomo. (2023) Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial. The Lancet Regional Health - Americas 18, pages 100423.
Crossref
Crossref
Thomas Hagan, Bram Gerritsen, Lewis E. Tomalin, Slim Fourati, Matthew P. Mulè, Daniel G. Chawla, Dmitri Rychkov, Evan Henrich, Helen E. R. Miller, Joann Diray-Arce, Patrick Dunn, Audrey Lee, A. Deckhut-Augustine, R. Gottardo, E. K. Haddad, D. A. Hafler, E. Harris, D. Farber, S. H. Kleinstein, O. Levy, J. McElrath, R. R. Montgomery, B. Peters, B. Pulendran, A. Rahman, E. F. Reed, N. Rouphael, M. M. Sarwal, R. P. Sékaly, A. Fernandez-Sesma, A. Sette, K. Stuart, A. Togias, J. S. Tsang, Ofer Levy, Raphael Gottardo, Minne M. Sarwal, John S. Tsang, Mayte Suárez-Fariñas, Rafick-Pierre Sékaly, Steven H. Kleinstein & Bali Pulendran. (2022) Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses. Nature Immunology 23:12, pages 1788-1798.
Crossref
Crossref
Satakshi Gupta, Neelam Sharma, Leimarembi Devi Naorem, Shipra Jain & Gajendra P.S. Raghava. (2022) Collection, compilation and analysis of bacterial vaccines. Computers in Biology and Medicine 149, pages 106030.
Crossref
Crossref
Nabamita Basu & Rina Ghosh. (2021) Recent chemical syntheses of bacteria related oligosaccharides using modern expeditious approaches. Carbohydrate Research 507, pages 108295.
Crossref
Crossref
Ravinder Mettu, Chiang-Yun Chen & Chung-Yi Wu. (2020) Synthetic carbohydrate-based vaccines: challenges and opportunities. Journal of Biomedical Science 27:1.
Crossref
Crossref
Parinaz Emami, Fatemeh Fallahianbijan, Erica Dinse, Seyed Pouria Motevalian, Brenda Carrillo Conde, Kelvin Reilly & Andrew L. Zydney. (2020) Modified intermediate pore blockage model describes fouling behavior during sterile filtration of glycoconjugate vaccines. Journal of Membrane Science 613, pages 118495.
Crossref
Crossref
Alexandros Psarris, Michael Sindos, Georgios Daskalakis, Maria Eleni Chondrogianni, Stefani Panayiotou, Panagiotis Antsaklis & Dimitrios Loutradis. (2019) Immunizations during pregnancy: How, when and why. European Journal of Obstetrics & Gynecology and Reproductive Biology 240, pages 29-35.
Crossref
Crossref
Abeer Sharyan, Cendy Gonzalez, Ophelia Ukaegbu, Kayla Powell & Pumtiwitt C. McCarthy. (2018) Determination of the binding affinities of Neisseria meningitidis serogroup W capsule polymerase with two nucleotide sugar substrates. BMC Research Notes 11:1.
Crossref
Crossref
Bogdan Aman & Gabriel Ciobanu. (2018) Bonding calculus. Natural Computing 17:4, pages 823-832.
Crossref
Crossref
K. Souliotis, C. Golna, N. Kotsopoulos, V. Kapaki & C. Dalucas. (2018) Meningitis B vaccination: knowledge and attitudes of pediatricians and parents in Greece. Heliyon 4:11, pages e00902.
Crossref
Crossref
Huifeng Yu, Yanming An, Marcos D. Battistel, John F. Cipollo & Darón I. Freedberg. (2018)
Improving Analytical Characterization of Glycoconjugate Vaccines through Combined High-Resolution MS and NMR: Application to
Neisseria meningitidis
Serogroup B Oligosaccharide-Peptide Glycoconjugates
. Analytical Chemistry 90:8, pages 5040-5047.
Crossref
Crossref
Pumtiwitt C. McCarthy, Abeer Sharyan & Laleh Sheikhi Moghaddam. (2018) Meningococcal Vaccines: Current Status and Emerging Strategies. Vaccines 6:1, pages 12.
Crossref
Crossref
Olaya Rendueles, Marc Garcia-Garcerà, Bertrand Néron, Marie Touchon & Eduardo P. C. Rocha. (2017) Abundance and co-occurrence of extracellular capsules increase environmental breadth: Implications for the emergence of pathogens. PLOS Pathogens 13:7, pages e1006525.
Crossref
Crossref
Myron Christodoulides & John Heckels. (2017) Novel approaches to Neisseria meningitidis vaccine design. Pathogens and Disease 75:3.
Crossref
Crossref
J. A. VÁZQUEZ, M. K. TAHA, J. FINDLOW, S. GUPTA & R. BORROW. (2016) Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiology and Infection 144:14, pages 3052-3057.
Crossref
Crossref
M. Mordu?A. ?timac, M. Brgles, T. Kurtovi?B. Halassy. (2016) Simple alternative to sialic acid determination in meningococcal polysaccharides W or Y. Journal of Pharmaceutical and Biomedical Analysis 120, pages 283-289.
Crossref
Crossref
Matthew J. Bottomley, Rino Rappuoli & Oretta Finco. 2016. The Vaccine Book. The Vaccine Book
45
65
.
Luke R. Green, Joseph Eiden, Li Hao, Tom Jones, John Perez, Lisa K. McNeil, Kathrin U. Jansen & Annaliesa S. Anderson. 2016. Vaccine Design. Vaccine Design
445
469
.
Marco Marradi, Fabrizio Chiodo & Isabel García. 2015. Carbohydrates in Drug Design and Discovery. Carbohydrates in Drug Design and Discovery
89
131
.
Darryl J. Hill, Natalie J. Griffiths, Elena Borodina, Clio A. Andreae, Richard B. Sessions & Mumtaz Virji. (2015) Identification and Therapeutic Potential of a Vitronectin Binding Region of Meningococcal Msf. PLOS ONE 10:3, pages e0124133.
Crossref
Crossref
Shamez N. Ladhani, Kazim Beebeejaun, Jay Lucidarme, Helen Campbell, Steve Gray, Ed Kaczmarski, Mary E. Ramsay & Ray Borrow. (2015) Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales. Clinical Infectious Diseases 60:4, pages 578-585.
Crossref
Crossref
R. Gasparini, D. Panatto, N. L. Bragazzi, P. L. Lai, A. Bechini, M. Levi, P. Durando & D. Amicizia. (2015)
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective
Neisseria meningitidis
Vaccines
. Journal of Immunology Research 2015, pages 1-26.
Crossref
Crossref
Andrew D. Cox, Frank St. Michael, Annie Aubry, Chantelle M. Cairns, Philippa C. R. Strong, Alexander C. Hayes & Susan M. Logan. (2013) Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection. Glycoconjugate Journal 30:9, pages 843-855.
Crossref
Crossref
Francesca Micoli, Maria Rosaria RomanoMarta TontiniEmilia Cappelletti, Massimiliano Gavini, Daniela ProiettiSimona Rondini, Erwin SwennenLaura SantiniSara FilippiniCristiana BalocchiRoberto AdamoGerd PluschkeGunnstein Norheim, Andrew PollardAllan Saul, Rino RappuoliCalman A. MacLennan, Francesco BertiPaolo Costantino. (2013) Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proceedings of the National Academy of Sciences 110:47, pages 19077-19082.
Crossref
Crossref
Matthew C. Cook, Alex Bliu & Jeremy P. Kunkel. (2013) Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: Optimisation of hydrolysis conditions and chromatographic methods. Vaccine 31:36, pages 3702-3711.
Crossref
Crossref
Matthew C. Cook, Sabrina Gibeault, Vasilisa Filippenko, Qiang Ye, Junzhi Wang & Jeremy P. Kunkel. (2013) Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China. Biologicals 41:4, pages 261-268.
Crossref
Crossref
Rolando Pajon, Andrew M. Fergus & Dan M. Granoff. (2013) Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa. PLoS ONE 8:6, pages e66536.
Crossref
Crossref
Robert M. Jacobson, Lisa A. Jackson, Keith Reisinger, Allen Izu, Tatjana Odrljin & Peter M. Dull. (2013) Antibody Persistence and Response to a Booster Dose of a Quadrivalent Conjugate Vaccine for Meningococcal Disease in Adolescents. Pediatric Infectious Disease Journal 32:4, pages e170-e177.
Crossref
Crossref
Saverio Caini, Nam Seon Beck, Harouna Yacouba, Idrissa Maiga, Ibrahim Chaibou, Ide Hinsa, Aboubacar Adakal, Aboubacar Issoufou, Sung Hye Kim & Lorenzo Pezzoli. (2013) From Agadez to Zinder: estimating coverage of the MenAfriVac? conjugate vaccine against meningococcal serogroup A in Niger, September 2010 ? January 2012. Vaccine 31:12, pages 1597-1603.
Crossref
Crossref
Susan M. Steenbergen & Eric R. Vimr. 2013. Bacterial Cell Surfaces. Bacterial Cell Surfaces
109
120
.
Patricia Kaaijk, Arie van der Ende, Guy Berbers, Germie PJM van den Dobbelsteen & Nynke Y Rots. (2012) Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands. BMC Infectious Diseases 12:1.
Crossref
Crossref
D. Roux, G. B. Pier & D. Skurnik. (2012) Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes. Journal of Antimicrobial Chemotherapy 67:12, pages 2785-2787.
Crossref
Crossref
Paul B Keiser & Christopher J Gill. (2012) Defining efficacy in meningococcal vaccine trials. Clinical Investigation 2:6, pages 589-601.
Crossref
Crossref
Shamez N. Ladhani, Jessica S. Flood, Mary E. Ramsay, Helen Campbell, Stephen J. Gray, Edward B. Kaczmarski, Richard H. Mallard, Malcolm Guiver, Lynne S. Newbold & Ray Borrow. (2012) Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines. Vaccine 30:24, pages 3710-3716.
Crossref
Crossref
Brian Greenwood, Emiliano Chiarot, Calman A. MacLennan & Miguel O’Ryan. (2012) Can we defeat meningococcal disease in low and middle income countries?. Vaccine 30, pages B63-B66.
Crossref
Crossref
Scott A. Halperin, Julie A. Bettinger, Brian Greenwood, Lee H. Harrison, Jane Jelfs, Shamez N. Ladhani, Peter McIntyre, Mary E. Ramsay & Marco A.P. Sáfadi. (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30, pages B26-B36.
Crossref
Crossref
David S Stephens. (2012) Prevention of serogroup B meningococcal disease. The Lancet 379:9816, pages 592-594.
Crossref
Crossref
Mariagrazia Pizza, Lisa DeTora & James Wassil. (2012) Advances in meningococcal vaccines. Clinical Practice 9:1, pages 101-117.
Crossref
Crossref
Maria Eugenia-Toledo-Romani, Mayra García Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodriguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raul González-Mugica, Oscar Samón-Tabío, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Melia-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Patrick Van der Stuyft Van der Stuyft, Sonsire Fernandez-Castillo, Yanet Climent-Ruiz, Yury Valdés-Balbín, Dagmar García-Rivera & Vicente Verez-Bencomo. (2022) Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-PLUS: Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial. SSRN Electronic Journal.
Crossref
Crossref